Lesion development in Marburg's type of acute multiple sclerosis: From inflammation to demyelination

Multiple Sclerosis

Volumn 5, Issue 3, 1999, Pages 138-146

  Bitsch, A ^a   Wegener, C ^a   Da Costa, C ^a   Bunkowski, S ^a   Reimers, C D ^a   Prange, H W ^a   Bruck W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Demyelination; iNOS; IVIG; Multiple sclerosis; Pathogenesis; TNF

Indexed keywords

IMMUNOGLOBULIN G; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD VESSEL WALL; BRAIN BIOPSY; BRAIN INJURY; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; COMPLEMENT ACTIVATION; DEMYELINATION; DISEASE COURSE; GASTROINTESTINAL INFECTION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEPOSITION; INFLAMMATION; INFLAMMATORY CELL; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NUCLEAR MAGNETIC RESONANCE IMAGING; STEREOTAXIC SURGERY; T LYMPHOCYTE; VIRUS HEMORRHAGIC FEVER; WHITE MATTER;

EID: 0033031925     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500302     Document Type: Article

References (33)

1. Hohlfeld R. (1997) Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120: 865-916.
2. Lucchinetti CF, Brück W, Rodriguez M, Lassman H. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6: 259-274.
3. Sriram S, Rodriguez M. (1997) Indictment of the microglia as the villain in multiple sclerosis. Neurology 48: 464-470.
4. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. (1993) Oligodendrocyte injury is an early event in lesions of multiple scelrosis. Mayo Clin Proc 68: 627-636.
5. Panitch H, Hirsch R, Schindler J, Johnson K. (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37: 1097-1102.
6. Lucchinetti CF, Rodriguez M. (1997) The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin Proc 72: 665-678.
7. Brück W et al. (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38: 788-796.
8. Brück W et al. (1997) Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42: 783-793.
9. Brück Y, Brück W, Kretzschmar HA, Lassmann H. (1996) Evidence for neuronal apoptosis in pontosubicular neuron necrosis. Neuropathol Appl Neurobiol 22: 23-29.
10. Breitschopf H et al. (1992) In situ hybridization with digoxigenine-labelled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol (Berl) 84: 581-587.
11. Bitsch A et al. (1998) Identification of macrophage populations expressing tumor necrosis factor alpha mRNA in acute multiple sclerosis. Acta Neuropathol (Berl) 95: 373-377.
12. Bitsch A et al. (1998) The use of PCR-generated cRNA probes for non radioactive in situ hybridization on paraffin-embedded brain tissue. E J Pathol 4: 981-986.
13. Poser S et al. (1992) Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 86: 579-585.
14. Graham DI, Lantos PL, (eds) (1996) Greenfields neuropathology, 6th edn. London: Arnold.
15. Brück W et al. (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35: 65-73.
16. Brosnan CF et al. (1989) Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit. J Neuroimmunol 25: 227-239.
17. Redford EJ, Kapoor R, Smith KJ. (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120: 2149-2157.
18. Ferguson B, Matyszak MK, Esiri MM, Perry VH. (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120: 393-399.
19. Diasio RF, LoBuglio AF. (1996) Immunomodulators: immunosuppressive agents and immunostimulants. In: Hardman JG, Limbird LE (ed.). Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. New York: MacGraw Hill.
20. Nguyen KB, McCombe PA, Pender MP. (1997) Increased apoptosis of T-lymphocytes and macrophages in the central nervous and peripheral nervous system of Lewis rats with experimental autoimmune encephalomyelitis treated with dexamethasone. J Neuropathol Exp Neurol 56: 58-69.
21. Fattal-German M, Le Roy Ladurie F, Lecerf F, Berrih-Aknin S. (1996) Expression of ICAM-1 and TNF alpha in human alveolar macrophages from lung-transplant recipients. Ann N Y Acad Sci 796: 138-148.
22. Navikas V, Link H. (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45: 322-333.
23. Parkinson JF, Mitrovic B, Merrill JE. (1997) The role of nitric oxide in multiple sclerosis. J Mol Med 75: 174-186.
24. Hisahara S, Shoji S, Okano H, Miura M. (1997) ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 69: 10-20.
25. Bogumil T, Rieckmann P, Kubuschok B, Brück W. (1998) Serum levels of macrophage-derived protein MRP-8/14 are elevated in multiple sclerosis. Neurosci Lett 247: 195-197.
26. Linington C et al. (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against myelin/ oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17: 61-69.
27. Ozawa K et al. (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311-1322.
28. Fazekas F et al. (1997) Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Lancet 349: 589-593.
29. Allen IV. (1991) Pathology of multiple sclerosis. In: Matthews WB (ed.). McAlpine's Multiple Sclerosis, 2nd edn. Edinburgh: Churchill Livingstone, pp 341-378.
30. Radzun HJ et al. (1991) Detection of a monocyte/ macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody KiM1P. Lab Invest 65: 306-315.
31. Bhardwaj RS et al. (1992) The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur J Immunol 22: 1891-1897.
32. Zwadlo G, Schlegel R, Sorg C. (1986) A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 137: 512-518.
33. Piddlesden SJ et al. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143: 555-564.